Should industry speak the loudest in informing the public on medical matters?

PLoS Med. 2006 Feb;3(2):e118; author reply e116. doi: 10.1371/journal.pmed.0030118. Epub 2006 Feb 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Advertising*
  • Biomedical Research / economics
  • Community Participation
  • Conflict of Interest
  • Depression / drug therapy
  • Depression / physiopathology*
  • Drug Industry*
  • Federal Government
  • Humans
  • Research Support as Topic
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin / metabolism

Substances

  • Serotonin Uptake Inhibitors
  • Serotonin